Efficacy of types and 5-year total and disease-free survival rates (%).
| Results | PCMZL | PCFCL | PCLBCL (lower limb) | PCLBCL (other) | Unknown | Total |
|---|---|---|---|---|---|---|
| CR | 2 (100) | 16 (88.9) | 7 (87.5) | - | 1 | 26 (86.7) |
| PR | - | 2 (11.1) | - | 1 | - | 3 (10) |
| Deterioration | - | - | 1 (12.5) | - | - | 1 (3.3) |
| Recurrence | 1 (50) | 9 (50) | 3 (43) | - | 1 | 14 (41.7) |